Viewing Study NCT06680258


Ignite Creation Date: 2025-12-25 @ 12:16 AM
Ignite Modification Date: 2026-03-09 @ 8:30 AM
Study NCT ID: NCT06680258
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-03
First Post: 2024-11-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy
Sponsor: Tempest Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module